Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Vomiting 1Precancerous Conditions 1Nausea 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Esomeprazole × Clear all
NCT04865731 2025-08-06

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
6 enrolled 7 charts
Head & Neck

Head and Neck Neoplasms

NCT00357682 2025-05-01

AspECT

University of Oxford

Phase 3 Completed
2,557 enrolled 17 charts
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated
43 enrolled 5 charts
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡